A lung cancer diagnosis can come with a lot of unfamiliar terms. You may hear phrases like “non-small cell lung cancer” or “genetic mutation” and wonder what they actually mean for you or your loved one.
Understanding these terms doesn’t require a medical background, but learning the basics can help you feel more confident as you navigate your care and explore your options.
Why Understanding Your Diagnosis Matters
Lung cancer can look different from person to person.
That’s why your diagnosis includes more than just “lung cancer.” It may also describe the type of cancer and whether there are specific genetic changes involved. These details can help guide treatment decisions and may open the door to potential new treatment options.
What Are the Main Types of Lung Cancer?
There are two primary types of lung cancer:
- Non-small cell lung cancer (NSCLC) is the most common type, making up about 85% of cases.
- Small cell lung cancer (SCLC) is a less common but faster-growing form.
NSCLC tends to grow more slowly than small cell lung cancer, and treatment options can vary depending on the subtype and stage.
What Are Genetic Mutations?
Inside every cell in your body are genes that act like instructions for how the cell should grow and function.
A genetic mutation is a change in those instructions. In cancer, certain mutations can cause cells to grow out of control.
While that may sound concerning, these mutations can also provide important clues for treatment. In some cases, doctors can use this information to match patients with therapies designed to target specific changes in the cancer.
This approach is often called personalized medicine, and it’s helping to reshape cancer care.
A Closer Look at KRAS
One mutation you may hear about in lung cancer is called KRAS G12C.
KRAS is a gene that helps regulate cell growth. When the gene changes, this can lead to cancer development.
For many years, KRAS mutations were difficult to treat with targeted therapies. Researchers are actively studying new treatment approaches designed specifically for cancers with this mutation.
What This Means for Treatment
Understanding the type of lung cancer you have and whether it includes a mutation like KRAS G12C can help guide your treatment plan.
Instead of a generic approach, care may now be tailored based on:
- The type of lung cancer
- How advanced it is
- The genetic changes driving it
This more personalized approach may offer additional options, including newer therapies being studied in research settings.
Hope Through Research
Clinical research studies are an important part of how new cancer treatments are developed.
They allow researchers to study new therapies or combinations of treatments to better understand how they work. For patients, clinical research studies may provide access to potential new treatment options.
They also play a critical role in making sure treatments are tested in diverse populations. This helps improve care for communities that have historically been underrepresented in research.
The Bottom Line
Learning about lung cancer types and genetic mutations can feel overwhelming, but it’s important to truly understand your unique diagnosis. Click here https://e.lilly/4edsTVV to explore ongoing research and see if a clinical research study may be right for you.
This article is sponsored by Lilly.
References:
American Lung Association. Types of Lung Cancer
American Lung Association. KRAS and Lung Cancer